Skip to content
HowShorted

OPKO Health, Inc. short interest in 2019

In 2019, OPKO Health, Inc.'s disclosed short interest ran from 10.59% of shares outstanding on 15 Jan 2019 to 12.14% on 31 Dec 2019, a change of +1.55 percentage points. The year's high was 15.54% on 31 May 2019 and its low 10.57% on 31 Jan 2019, averaging 13.48% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 33.13 days on 31 Jul 2019. Full history: OPKO Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for OPKO Health, Inc. in 2019

2019 in figures

Start of year
10.59% (15 Jan 2019)
End of year
12.14% (31 Dec 2019)
Change
+1.55 pp
High
15.54% (31 May 2019)
Low
10.57% (31 Jan 2019)
Average
13.48%
Highest days to cover
33.13 (31 Jul 2019)
SEC filings marked
8

Every report in 2019

OPKO Health, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201910.59%12.48
31 Jan 201910.57%17.34
15 Feb 201911.60%8.15
28 Feb 201913.18%12.09results (8-K)
15 Mar 201914.52%14.4410-K filed
29 Mar 201915.18%18.07
15 Apr 201915.46%28.69
30 Apr 201914.14%19.73
15 May 201914.82%13.45results (8-K), 10-Q filed
31 May 201915.54%23.45
14 Jun 201915.34%27.97
28 Jun 201914.80%14.75
15 Jul 201914.75%24.09
31 Jul 201914.27%33.13
15 Aug 201914.81%19.6110-Q filed, results (8-K)
30 Aug 201914.49%32.63
13 Sep 201914.45%27.64
30 Sep 201913.97%24.63
15 Oct 201913.77%24.33
31 Oct 201911.20%7.56
15 Nov 201911.34%13.4310-Q filed, results (8-K)
29 Nov 201911.17%16.26
13 Dec 201911.50%23.36
31 Dec 201912.14%17.75

See also: OPKO Health, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.